New potential antitumoral fluorescent tetracyclic thieno[3,2-b]pyridine derivatives: interaction with DNA and nanosized liposomes by Castanheira, Elisabete MS et al.
NANO EXPRESS Open Access
New potential antitumoral fluorescent tetracyclic
thieno[3,2-b]pyridine derivatives: interaction with
DNA and nanosized liposomes
Elisabete MS Castanheira
1*, Maria Solange D Carvalho
1,2, Ana Rita O Rodrigues
1, Ricardo C Calhelha
2 and
Maria-João RP Queiroz
2
Abstract
Fluorescence properties of two new potential antitumoral tetracyclic thieno[3,2-b]pyridine derivatives were studied
in solution and in liposomes of DPPC (dipalmitoyl phosphatidylcholine), egg lecithin (phosphatidylcholine from
egg yolk; Egg-PC) and DODAB (dioctadecyldimethylammonium bromide). Compound 1, pyrido[2’,3’:3,2]thieno[4,5-d]
pyrido[1,2-a]pyrimidin-6-one, exhibits reasonably high fluorescence quantum yields in all solvents studied (0.20 ≤
FF ≤ 0.30), while for compound 2, 3-[(p-methoxyphenyl)ethynyl]pyrido[2’,3’:3,2]thieno[4,5-d]pyrido[1,2-a]pyrimidin-6-
one, the values are much lower (0.01 ≤ FF ≤ 0.05). The interaction of these compounds with salmon sperm DNA
was studied using spectroscopic methods, allowing the determination of intrinsic binding constants, Ki = (8.7 ± 0.9)
×1 0
3 M
-1 for compound 1 and Ki = (5.9 ± 0.6) × 10
3 M
-1 for 2, and binding site sizes of n = 11 ± 3 and n =7±2
base pairs, respectively. Compound 2 is the most intercalative compound in salmon sperm DNA (35%), while for
compound 1 only 11% of the molecules are intercalated. Studies of incorporation of both compounds in
liposomes of DPPC, Egg-PC and DODAB revealed that compound 2 is mainly located in the hydrophobic region of
the lipid bilayer, while compound 1 prefers a hydrated and fluid environment.
Introduction
Liposomes are among technological delivery develop-
ments for chemotherapeutic drugs in the treatment of
cancer. This technique can potentially overcome many
common pharmacologic problems, such as those invol-
ving solubility, pharmacokinetics, in vivo stability and
toxicity [1-3]. Liposomes are closed spherical vesicles
consisting of a lipid bilayer that encapsulates an aqueous
phase in which hydrophilic drugs can be stored, while
water insoluble compounds can be incorporated in the
hydrophobic region of the lipid bilayer [4].
In this work, two new potential antitumoral fluorescent
planar tetracyclic thieno[3,2-b]pyridine derivatives 1 and 2
(Figure 1), previously synthesized by some of us [5], were
encapsulated in liposomes of DPPC (dipalmitoyl phospha-
tidylcholine), egg lecithin (phosphatidylcholine from egg
yolk) and DODAB (dioctadecyldimethylammonium
bromide). DPPC and egg lecithin [egg yolk phosphatidyl-
choline (Egg-PC)] are neutral components of biological
membranes, while cationic liposomes based on the syn-
thetic lipid DODAB have been used as vehicles for DNA
transfection and drug delivery [6]. These studies are
important keeping in mind future drug delivery applica-
tions using these compounds as anticancer drugs.
Due to the antitumoral potential of the two com-
pounds 1 and 2, related with their possible intercalation
between the DNA base pairs, interactions with natural
double-stranded salmon sperm DNA were studied.
These interactions can be assessed using spectroscopic
measurements, which are important tools for monitor-
ing DNA-binding processes. The investigation based on
DNA interactions has a key importance in order to
understand the mechanisms of action of antitumor and
antiviral drugs and to design new DNA-targeted drugs
[7,8]. Small molecules are stabilized on groove binding
and intercalation with DNA through a series of associa-
tive interactions such as π-stacking, hydrogen bonding,
attractive van der Waals and hydrophobic interactions
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any medium, provided the original work is properly cited.[8]. The occurrence of intercalation seems to be an
essential (but not sufficient) step for antitumoral activity
[7]. Fluorescence quenching experiments using external
quenchers are also very useful to distinguish between
DNA binding modes [9] since intercalated molecules are
less accessible to anionic quenchers due to electrostatic
repulsion with negatively charged DNA [10].
Experimental
Salmon sperm DNA from Invitrogen (Carlsbad, CA,
USA) and compounds stock solutions were prepared in
10 mM Tris-HCl buffer (pH = 7.4), with 1 mM EDTA.
The DNA concentration in number of bases was deter-
mined from the molar absorption coefficient, ε =6 6 0 0
M
-1 cm
-1 at 260 nm [11]. Fluorescence spectra of several
solutions with different [DNA]/[compound] ratios and
constant compound concentration (5 × 10
-6 M) were
recorded. The solutions were left several hours to
stabilize.
Dipalmitoyl phosphatidylcholine (DPPC), egg yolk
phosphatidylcholine (Egg-PC), from Sigma-Aldrich (St.
Louis, Missouri, USA), and dioctadecyldimethylammo-
nium bromide (DODAB), from Tokyo Kasei (Tokyo,
Japan), were used as received. Liposomes were prepared
by the ethanolic injection method, previously used for
the preparation of Egg-PC and DPPC liposomes [12-15]
and DODAB vesicles [16,17]. An ethanolic solution of a
lipid/compound mixture was injected in an aqueous
buffer solution under vigorous stirring, above the melt-
ing transition temperature of the lipid (approx. 41°C for
DPPC [18] and 45°C for DODAB [19]). The final lipid
concentration was 1 mM, with a compound/lipid molar
ratio of 1:500. One millilitre solutions of liposome dis-
persions were placed in 3 mL disposable polystyrene
cuvettes for dynamic light scattering (DLS) measure-
ments in a Malvern ZetaSizer Nano ZS particle analyzer
(Worcestershire, UK). Five independent measurements
were performed for each sample. Malvern Dispersion
Technology Software (DTS) (Worcestershire, UK) was
used with multiple narrow mode (high resolution) data
processing, and mean size (nm) and error values were
considered.
Absorption spectra were recorded in a Shimadzu UV-
3101PC UV-Vis-NIR spectrophotometer (Kyoto, Japan)
and fluorescence measurements were obtained in a
Fluorolog 3 spectrofluorimeter (HORIBA Scientific,
Kyoto, Japan) equipped with Glan-Thompson polarizers.
Fluorescence spectra were corrected for the instrumen-
tal response of the system. The fluorescence quantum
yields were determined by the standard method [20,21],
using 9,10-diphenylanthracene in ethanol as reference,
Fr = 0.95 [22]. The solutions were previously bubbled
for 20 min with ultrapure nitrogen.
Results and discussion
The size and size distribution of the liposomes prepared
was obtained by DLS. All the liposomes have a mean
hydrodynamic radius lower than 150 nm and generally
low polydispersity. For Egg-PC and DODAB liposomes,
the size distributions are bimodals and broader than for
DPPC liposomes, the Egg-PC being the more polydis-
perse (Figure 2). The ethanolic injection method was
described to produce phospholipid small unilamellar
vesicles (SV) [12-15]. Accordingly, DPPC and Egg-PC
liposomes obtained here are in this category, with a
mean diameter of around 90 nm for DPPC and 50 nm
for Egg-PC. DODAB liposomes exhibit a significantly
larger mean diameter (around 270 nm) than the phos-
pholipid ones. The size of DODAB vesicles strongly
depends on the preparation method, sonication and
ethanolic injection giving small DODAB vesicles
[17,23,24], while injection using chloroform yielded
large DODAB vesicles [16]. Besides, spontaneously pre-
pared DODAB liposomes have a much larger size
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Figure 1 Structure of the compounds 1 and 2.
Figure 2 Size distributions obtained by dynamic light
scattering (DLS) for DPPC, Egg-PC and DODAB liposomes
prepared by the ethanolic injection method.
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sidered giant unilamellar vesicles (GUV). The DODAB
liposomes mean diameter obtained here (ca. 270 nm)
compares well with the reported value of 249 nm for
DODAB SV [16]. In all samples, no experimental evi-
dence of the presence of open bilayer fragments (dia-
meter lower than 10 nm [17]) was obtained (Figure 2).
The absorption and fluorescence properties of com-
pounds 1 and 2 were studied in several solvents (Table
1). The normalized fluorescence spectra of compounds
1 and 2 are shown in Figures 3 and 4. The fluores-
cence emission maximum of both compounds displays
a loss of vibrational structure in polar solvents
together with a small red shift (Figures 3 and 4), indi-
cating some charge transfer character of the excited
state [26]. The red shifts are more significant for com-
pound 2 (Table 1), which may be due to a higher cap-
ability of this compound to establish hydrogen bonds
with protic solvents (especially with water), due to the
presence of the OCH3 group. Compound 1 has signifi-
cantly higher fluorescence quantum yields (between 20
a n d3 0 % )t h a nc o m p o u n d2 (FF between 1 and 5%),
showing that the functionalization of the pyridine ring
with a triple bond linked to a p-methoxyphenyl group
causes a significant enhance of the non-radiative deac-
tivation pathways. The fluorescence quantum yields of
compound 1 are also higher than the ones of a benzo
[b]thiophene derivative of the same type, a benzothie-
nopyridopyrimidone [27], in which the benzene ring
linked to the thiophene is substituted in compound 1
by a pyridine ring. The intrinsic fluorescence of
compounds 1 and 2 can be used to monitor interac-
tions with DNA and compounds behaviour when
encapsulated in liposomes.
Both compounds 1 and 2 were tested for their interac-
tion with natural salmon sperm DNA using spectro-
scopic methods. For compound 1, fluorescence intensity
decreases with increasing DNA concentration, while the
opposite happens for compound 2 (Figures 5 and 6).
This behaviour, also previously observed for differently
substituted tetracyclic lactams [28], may indicate a dif-
ferent type of interaction of both compounds with the
DNA molecule. For the two compounds, full saturation
(corresponding to spectral invariance with increasing
DNA concentration) is attained at [DNA]/[compound]
= 200, meaning that total binding is achieved at this
ratio. The high [DNA]/[compound] ratio needed for
total binding, together with the negligible changes
observed in absorption spectra (not shown), point to a
weak interaction of these molecules with the nucleic
acid.
The intrinsic binding constants (Ki) and binding site
sizes (n) were determined (Table 2) through the
McGhee and von Hippel modification of Scatchard plot
(Equation 1) [29],
r
cf
= Ki (1 − nr)

(1 − nr)

(1 − (n − 1)r)
 n−1 (1)
where Ki is the intrinsic binding constant, n the bind-
ing site size, r the ratio cb/[DNA] and cb and cf the con-
centrations of bound and free compound, respectively,
calculated by
Table 1 Maximum absorption (labs) and emission (lem) wavelengths, molar absorption coefficients (ε) and
fluorescence quantum yields of compounds 1 and 2 in several solvents
Solvent labs (nm) (ε/10
4 M
-1 cm
-1) lem (nm) FF
12 1 2 1 2
Cyclohexane 398 (0.84); 377 (1.24); 360 (1.27); 305
(0.95); 258 (3.93)
411 sh (0.33); 354 (2.19); 347 (2.37); 308 (1.25); 291
(1.12); 270 (1.40)
402; 426;
452 sh
417;
441
0.20 0.047
Dioxane 398 (0.76); 377 (1.18); 359 (1.20); 305
(1.17); 258 (3.60)
411 sh (0.66); 356 (5.36); 346 (5.40); 309 (3.23); 291
(2.98); 272 (3.33)
407; 428;
455 sh
425;
449
0.29 0.054
Dichloromethane 397 (0.58); 377 (0.91); 360 (0.93); 305
(0.97); 259 (2.70)
410 sh (0.55); 357 (4.37); 311 (2.28); 290 (2.29); 273
(2.78)
408; 429 427;
448
0.26 0.022
Acetonitrile 395 (0.68); 376 (1.06); 358 (1.06); 304
(1.09); 256 (3.32)
409 sh (0.66); 355 (5.76); 308 (3.41); 289 (3.20); 271
(3.67)
408; 428 450 0.21 0.036
N,N-
Dimethylformamide
a
397 (0.78); 377 (1.19); 360 (1.16); 305
(1.19)
411 sh (0.69); 356 (5.52); 311 (3.11); 290 (2.86) 411; 430 453 0.30 0.047
Dimethylsulfoxide
a 397 (0.77); 378 (1.17); 361 (1.14); 305
(1.17)
412 sh (0.61); 357 (4.70); 313 (2.52) 413; 432 455 0.28 0.048
Ethanol 396 (0.69); 375 (1.13); 358 (1.17); 304
(1.40); 256 (3.59)
408 sh (0.72); 355 (5.50); 311 (2.95); 272 (3.69) 412; 431 452 0.27 0.041
Methanol 395 (0.67); 374 (1.08); 358 (1.10); 304
(1.34); 256 (3.43)
408 sh (0.62); 354 (5.00); 311 (2.80); 272 (3.41) 413; 433 453 0.26 0.040
Water 394 (0.41); 374 (0.57); 361 (0.58); 303
(0.93); 256 (2.07)
420 sh (0.26); 358 (0.87); 314 (0.94); 278 (0.97) 413 sh; 433 505 0.22 0.012
aSolvent cut-offs: N,N-Dimethylformamide: 275 nm; Dimethylsulfoxide: 280 nm; sh: shoulder.
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IF,0 − IF
IF,0 − IF,b
× ctotal; ctotal = cf + cb (2)
being IF,0 the fluorescence intensity of the free com-
pound and IF,b the fluorescence intensity of the bound
compound at total binding. The binding constants
(Table 2) are moderately low, with a large number of
base pairs between consecutive intercalated compound
molecules (n).
Anionic quenchers can be useful in distinguishing
between DNA binding modes [9,10]. Compounds that
Figure 3 Normalized fluorescence spectra (lexc = 360 nm) of compound 1 (4 × 10
-6 M) in several solvents; the inset shows the
absorption spectrum of 1 in dichloromethane (1 × 10
-4 M) as an example.
Figure 4 Normalized fluorescence spectra (lexc = 360 nm) of compound 2 (4 × 10
-6 M) in several solvents; the inset shows the
absorption spectrum of 2 in dichloromethane (2 × 10
-5 M) as an example.
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trostatic binding) are more accessible and emission from
these molecules can be quenched more efficiently.
Fluorescence quenching measurements using iodide ion
showed that the usual Stern-Volmer plots (plots of the
fluorescence intensity ratio in the absence, I0,a n d
presence, I, of quencher vs. quencher concentration) are
not linear and exhibit a downward curvature (Figure
7A). This indicates that some compound molecules are
not accessible to the anionic quencher, being interca-
lated between DNA base pairs. The modified Stern-Vol-
mer plot [30] (Equation 3) allows the determination of
Figure 5 Fluorescence spectra of compound 1 (5 × 10
-6 M) in 0.01 M Tris-HCl buffer (pH = 7.2), with increasing DNA content.
Figure 6 Fluorescence spectra of compound 2 (5 × 10
-6 M) in 0.01 M Tris-HCl buffer (pH = 7.2), with increasing DNA content.
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quencher,
I0
 I
=
1
fa
+
1
fa KSV [Q]
(3)
where I0 is the fluorescence intensity in the absence of
quencher, ΔI = I0 - I, KSV the Stern-Volmer constant,
[Q] the quencher concentration and fa the fraction of
molecules accessible to quencher.
The representations of the modified Stern-Volmer plot
are reasonably linear (Figure 7B) and the fa values are in
Table 2. Both compounds exhibit some intercalation in
DNA, compound 2 being the more intercalative one,
with a lower fraction (65%) of molecules accessible to
anionic quencher. The higher hydrophobic character of
compound 2, promoted by the functionalization of the
pyridine with a triple bond linked to a p-methoxyphenyl
group, may justify this behaviour. As both compounds 1
and 2 are neutral molecules (and electrostatic interac-
tion with the negatively charged DNA molecule is not
expected), the high fa values indicate that the main type
of interaction with the nucleic acid must be the binding
to DNA grooves [28].
Fluorescence experiments of both compounds encap-
sulated in liposomes of DPPC, DODAB and Egg-PC
were carried out (Figure 8), in both gel (below Tm)a n d
liquid-crystalline (above Tm) phases. The melting transi-
tion temperature of Egg-PC is very low [31] and this
lipid is in the fluid liquid-crystalline phase at room tem-
perature. Fluorescence spectra of compound 1 incorpo-
rated in liposomes (Figure 8, Table 3) are roughly
similar to the one obtained in pure water, regarding the
band shape and maximum emission wavelength. Com-
pound 2 in liposomes presents emission spectra similar
to those in polar solvents, significantly blue-shifted rela-
tive to water. In Egg-PC, a band enlargement is
observed in the blue region, which can indicate two dif-
ferent locations of compound 2 in these liposomes, one
deep in the hydrophobic region and another more close
to the lipid polar heads.
Fluorescence anisotropy (r) measurements (Table 3)
can give relevant information about the location of the
compounds in liposomes, as r increases with the rota-
tional correlation time of the fluorescent molecule
(and, thus, with the viscosity of the fluorophore envir-
onment) [26]. Anisotropy values in a viscous solvent
(glycerol) were also determined, for comparison. Ani-
sotropy results (Table 3) allow to conclude that com-
pound 2 is mainly located in the inner region of the
lipid bilayer, feeling the penetration of some water
molecules. The transition from the rigid gel phase to
Table 2 Values of the intrinsic binding constants (Ki) and
binding site sizes (n) and fraction of compound
molecules accessible to external quenchers (fa) for
interaction with salmon sperm DNA
Compound Ki (M
-1) nf a
1 (8.7 ± 0.9) × 10
3 11 ± 3 0.89
2 (5.9 ± 0.6) × 10
3 7 ± 2 0.65
Figure 7 Stern-Volmer plots for quenching with iodide ion of compounds 1 and 2 for [DNA]/[compound] = 200 (A) and corresponding
modified Stern-Volmer plots (B).
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nificant decrease in anisotropy at 55°C observed in
DPPC and DODAB liposomes. Compound 1 exhibits a
different behaviour and anisotropy is very low in all
types of liposomes (and much lower than in glycerol,
Table 3). Overall, the results indicate that compound 1
prefers a hydrated and fluid environment and the tran-
sition from the gel phase to the liquid-crystalline phase
is not detected. To further clarify the location of com-
pound 1, the solutions of liposomes with incorporated
compound were passed through filters of 0.05 μmd i a -
meter. The fluorescence emission of the filtered solu-
tions was negligible, indicating that compound 1 is
mainly in the liposome aqueous interior or located at
the interfaces, with a very hydrated environment. This
behaviour is similar to the observed previously for a
benzothienopyridopyrimidone in lipid vesicles [27].
The encapsulation assays performed here may be
important for future drug delivery applications of these
potential antitumoral compounds using liposomes as
drug carriers.
Conclusions
The interaction with DNA of two new potential antitu-
moral fluorescent planar thieno[3,2-b]pyridine deriva-
tives was studied using spectroscopic methods.
Compound 2 was shown to be the most intercalative
compound in salmon sperm DNA (35%). The binding to
DNA grooves seems to be the main type of interaction
with the nucleic acid. Studies of incorporation of both
compounds in liposomes of DPPC, Egg-PC and DODAB
revealed that compound 2 is mainly located in the
hydrophobic region of the lipid bilayer, while compound
1 prefers a hydrated and fluid environment. Our data
thus suggest that both potential antitumoral compounds
may be transported in liposomes for drug delivery
applications.
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